Embed Size (px)
DESCRIPTION
A presentation by Wim Leereveld at TBLI CONFERENCE EUROPE 2008.
Citation preview
TBLI Conference November 2008
What defines the Access to Medicine Index
a yearly ranking of pharmaceutical companies on
efforts to provide global access to medicines?
TBLI Conference November 2008
How to engage the pharmaceutical industry through
transparency?
Scope, Results and Benefits of the Access to Medicine Index
TBLI Conference November 2008
TBLI Conference November 2008
80% of the population80% of the population20% of the medicine20% of the medicine
20% of the population20% of the population80% of the medicine80% of the medicine
TBLI Conference November 2008
How come?
TBLI Conference November 2008
Pharmaceutical Industry
responsible?
TBLI Conference November 2008
Should
they be involved?
Pharmaceutical Industry
TBLI Conference November 2008
Access to Medicine in developing countries:
is part of their CSR policymeans market presence and future growth
is important for their image
Pharmaceutical Industry
TBLI Conference November 2008
Can we help them to take a better role?
Yes, we can!
Pharmaceutical Industry
TBLI Conference November 2008
If you want to change something, you should first know where you
are
ATM Index measures where individual Pharmaceutical companies are on the path of improving access to medicine in developing countries
TBLI Conference November 2008
How?
TBLI Conference November 2008
TBLI Conference November 2008
The Challenge
TBLI Conference November 2008
Access to Medicine IndexEngaging industry through
transparency
Defines benchmarks on the role industry could play in improving ATM
Measures and ranks top 20 pharma companies
TBLI Conference November 2008
November 15th 2007:
“Innovest Selected as the Best ESG Consultancy/Research House”
Innovest Strategic Value Advisors was selected as the Best ESG Consultancy/ Research House by TBLI and Investment & Pensions Europe at the first ever ESG Leaders Awards for the investors, investment management and research community.
InnovestSTRATEGIC VALUE ADVISORS
InnovestSTRATEGIC VALUE ADVISORS
TBLI Conference November 2008
SUPPORT FROM DAY ONE
TBLI Conference November 2008
TBLI Conference November 2008
The road towards consensus
TBLI Conference November 2008
Index Model
TBLI Conference November 2008
TBLI Conference November 2008
Access to Medicine Index 2008Industry leaders - Perform well on most Index Criteria significant Access to Medicine strategy strong access to medicine management systems relatively transparent in public policy and advocacy equitable pricing and licensing agreements to increase greater access to affordable
drugs investing in R&D programs
Middle ranked companies – Less sophisticated strategies Do have specific access to medicine programs in place fail to consistently address all key issues in the access to medicine debate.
Lower ranked companies – Do not consider AtM as a key issue No formal access to medicine policy disclose little information on their efforts to improve access to medicine. no clear commitment to respond to access to medicine challenges in the
future.
TBLI Conference November 2008
Does this work?
Access to Medicine Index as a tool for
improvement:
Best practices are defined and recognized Companies want to perform well in rankings Rankings are tools for investors
TBLI Conference November 2008
Interest investors
• Indicator for good management -> Long term profit• Ready for business in developing countries• Use image in negotiations
TBLI Conference November 2008
$ 1.5 trillion Investor Support
TBLI Conference November 2008
Transparency benefits World attention for the ATM problem via
press coverage Investors get opportunity to play their role Analysing best practises, no excuses for
inabilities Companies increase performance
according to their ranking Companies are rewarded for good
behaviour Use of the data by a variety of
stakeholdersTBLI Conference November 2008
Support
www.atmindex.org
TBLI Conference November 2008
TBLI Conference November 2008
